Join Europe’s leading platform for AMR innovation! Connect with top stakeholders from industry, SMEs, finance, hospitals, science, and policy, and gain a 360° perspective on the latest breakthroughs.

The AMR Conference has grown over the past decade into one of the leading international platforms dedicated to tackling one of the most pressing health challenges of our time: antimicrobial resistance. It brings together SMEs, start-ups, big pharma, academia, investors, and public institutions to explore strategies and address the real-world hurdles of advancing novel antimicrobial treatments and diagnostics.

True to its mission, the conference covers the full innovation value chain – from early scientific discoveries and preclinical research to clinical development, funding models, and strategies for sustainable market access. Dedicated tracks explore opportunities in financing, public funding for R&D, manufacturing, and investors’ perspectives.

Swiss Biotech Association's members benefit from 20% discount for their tickets. Please reach out to our office to obtain the code.